FDA
-
-
-
-
-
-
-
Nkarta (NKTX) Initiates Clinical Trial of NKX019
-
-
-
-
-
-
-
Nkarta Reports Second Quarter 2022 Financial Results and Corporate Highlights
-
-
-
-
-
-
-
Nkarta (NKTX) Announces Updates to NKX019 and NKX101 Clinical Development Programs
-
-
-
-
-
-
-
Nkarta Reports Third Quarter 2020 Financial Results
-
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

